Table of Contents Author Guidelines Submit a Manuscript
Psychiatry Journal
Volume 2018, Article ID 5183834, 6 pages
https://doi.org/10.1155/2018/5183834
Clinical Study

Predictors of Broad Dimensions of Psychopathology among Patients with Panic Disorder after Cognitive-Behavioral Therapy

1Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
2Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan

Correspondence should be addressed to Sei Ogawa; moc.ytfin@4691awagoies

Received 3 October 2017; Revised 18 January 2018; Accepted 8 February 2018; Published 12 March 2018

Academic Editor: Umberto Albert

Copyright © 2018 Sei Ogawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. C. Kessler, P. Berglund, O. Demler, R. Jin, K. R. Merikangas, and E. E. Walters, “Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication,” Archives of General Psychiatry, vol. 62, no. 6, pp. 593–602, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. T. A. Brown, M. M. Antony, and D. H. Barlow, “Diagnostic Comorbidity in Panic Disorder: Effect on Treatment Outcome and Course of Comorbid Diagnoses Following Treatment,” Journal of Consulting and Clinical Psychology, vol. 63, no. 3, pp. 408–418, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. J. C. I. Tsao, M. R. Lewin, and M. G. Craske, “The effects of cognitive-behavior therapy for panic disorder on comorbid conditions,” Journal of Anxiety Disorders, vol. 12, no. 4, pp. 357–371, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. G. M. Goodwin, “The overlap between anxiety, depression, and obsessive-compulsive disorder,” Dialogues in Clinical Neuroscience, vol. 17, no. 3, pp. 249–260, 2015. View at Google Scholar · View at Scopus
  5. M. B. Keller, P. W. Lavori, I. M. Goldenberg et al., “Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo,” Journal of Affective Disorders, vol. 28, no. 1, pp. 27–38, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Ino, S. Ogawa, M. Kondo et al., “Anxiety sensitivity as a predictor of broad dimensions of psychopathology after cognitive behavioral therapy for panic disorder,” Neuropsychiatric Disease and Treatment, vol. 13, pp. 1835–1840, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. L. B. Allen, K. S. White, D. H. Barlow, M. K. Shear, J. M. Gorman, and S. W. Woods, “Cognitive-behavior therapy (CBT) for panic disorder: Relationship of anxiety and depression comorbidity with treatment outcome,” Journal of Psychopathology and Behavioral Assessment, vol. 32, no. 2, pp. 185–192, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. M. W. Otto and C. Deveney, “Cognitive-behavioral therapy and the treatment of panic disorder: efficacy and strategies,” Journal of Clinical Psychiatry, vol. 66, Suppl 4, no. 10, pp. 28–32, 2005. View at Google Scholar
  9. A. Pompoli, T. A. Furukawa, H. Imai, A. Tajika, O. Efthimiou, and G. Salanti, “Psychological therapies for panic disorder with or without agoraphobia in adults: A network meta-analysis,” Cochrane Database of Systematic Reviews, vol. 2016, no. 4, Article ID CD011004, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. M. G. Craske, T. J. Farchione, L. B. Allen, V. Barrios, M. Stoyanova, and R. Rose, “Cognitive behavioral therapy for panic disorder and comorbidity: More of the same or less of more?” Behaviour Research and Therapy, vol. 45, no. 6, pp. 1095–1109, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. S. E. Alaoui, E. Hedman, B. Ljótsson et al., “Predictors and moderators of internet- and group-based cognitive behaviour therapy for panic disorder,” PLoS ONE, vol. 8, no. 11, Article ID e79024, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Tomioka, M. Shimura, M. Hidaka, and C. Kubo, “The reliability and validity of a Japanese version of symptom checklist 90 revised,” BioPsychoSocial Medicine, vol. 2, p. 19, 2008. View at Google Scholar
  13. J. S. Ogrodniczuk, W. E. Piper, A. S. Joyce, M. McCallum, and J. S. Rosie, “NEO-five factor personality traits as predictors of response to two forms of group psychotherapy,” International Journal of Group Psychotherapy, vol. 53, no. 4, pp. 417–442, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Ogawa, R. Imai, M. Kondo, T. A. Furukawa, and T. Akechi, “Predictors of Comorbid Psychological Symptoms among Patients with Social Anxiety Disorder after Cognitive-Behavioral Therapy,” Open Journal of Psychiatry, vol. 06, no. 01, pp. 102–106, 2016. View at Publisher · View at Google Scholar
  15. A. Hoffart and L. M. Hedley, “Personality traits among panic disorder with agoraphobia patients before and after symptom-focused treatment,” Journal of Anxiety Disorders, vol. 11, no. 1, pp. 77–87, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Nakano, K. Lee, Y. Noda et al., “Cognitive-behavior therapy for Japanese patients with panic disorder: Acute phase and one-year follow-up results,” Psychiatry and Clinical Neurosciences, vol. 62, no. 3, pp. 313–321, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. B. First, Structured clinical interview for DSM-IV axis I disorders: SCID - I: clinician version: administration booklet, American Psychiatric Press, Washington, D.C., USA, 1997.
  18. T. A. Furukawa, N. Watanabe, and R. Churchill, “Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: Systematic review,” The British Journal of Psychiatry, vol. 188, pp. 305–312, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Watanabe, R. Churchill, and T. A. Furukawa, “Combined psychotherapy plus benzodiazepines for panic disorder.,” Cochrane Database of Systematic Reviews (Online), no. 1, p. CD005335, 2009. View at Google Scholar · View at Scopus
  20. G. Andrews, M. Creamer, R. Crino, C. Hunt, L. Lampe, and A. Page, The treatment of anxiety disorders: clinician guides and patient manuals, Cambridge University Press, Cambridge, UK, 2nd edition, 2003.
  21. P. T. Costa and R. R. McCrae, Revised neo personality inventory (neo pi-r) and neo five-factor inventory (neo-ffi), Psychological Assessment Resources Odessa, FL, USA, 1992.
  22. K. Yoshimura, Y. Ono, K. Nakamura, J. H. Nathan, and K. Suzuki, “Validation of the Japanese version of the neo five-factor inventory in a large community sample,” Psychological Reports, vol. 88, no. 2, pp. 443–449, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. L. R. Derogatis, SCL-90-R : administration, scoring & procedures manual -II, for the R (evised) version and other instruments of the psychopathology rating scale series, Clinical Psychometric Research, Towson, Md., USA, 2nd edition, 1992.
  24. T. A. Furukawa, M. Nakanishi, A. Sakurai, and A. Suzuki, “Effects of rthyl loflazepate in mood and neurosis-related disorders (ICD-10 JCM) ; Changes in SCL-90-R subscale scores,” Rinsho Seisinigaku (Clinical Psychiatry), vol. 25, pp. 233–240, 1996. View at Google Scholar
  25. D. L. Chambless, G. C. Caputo, P. Bright, and R. Gallagher, “Assessment of fear of fear in agoraphobics: The Body Sensations Questionnaire and the Agoraphobic Cognitions Questionnaire,” Journal of Consulting and Clinical Psychology, vol. 52, no. 6, pp. 1090–1097, 1984. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Noda, Y. Nakano, K. Lee et al., “Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder,” BMC Psychiatry, vol. 7, article no. 70, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Lee, Y. Noda, Y. Nakano et al., “Interoceptive hypersensitivity and interoceptive exposure in patients with panic disorder: Specificity and effectiveness,” BMC Psychiatry, vol. 6, article no. 32, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Katherine Shear, T. A. Brown, D. H. Barlow et al., “Multicenter collaborative panic disorder severity scale,” The American Journal of Psychiatry, vol. 154, no. 11, pp. 1571–1575, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Yamamoto, Y. Nakano, N. Watanabe et al., “Cross-cultural evaluation of the Panic Disorder Severity Scale in Japan,” Depression and Anxiety, vol. 20, no. 1, pp. 17–22, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. SPSS, SPSS for Windows (Version 18.0), vol. 2009.
  31. E. Fernandez, D. Salem, J. K. Swift, and N. Ramtahal, “Meta-analysis of dropout from cognitive behavioral therapy: Magnitude, timing, and moderators,” Journal of Consulting and Clinical Psychology, vol. 83, no. 6, pp. 1108–1122, 2015. View at Publisher · View at Google Scholar · View at Scopus